RSS

ALERTS, HOT STOCKS & CHARTS

Last Post: 6:01 PM
Followers: 548
Posts Today: 4
Views Today: 15743
  1. stockstock
  2. Dischino

Top 10 Most Recent News Articles

Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 1

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
State Business Formation Trends: Key Insights for Investors

Updated Category News Views 4

Grasping New Business Formation Shifts The fresh ink isn't dry yet on the latest figures from Registered Agents Inc, revealing a surge in entrepreneurial spark throughout the U.S. September 2026 smashed records with over 562,579 new business registrations—the first time this month crossed the half-million threshold. Quite the feat, really, showcasing a 14% uptick from...

Continue Reading
Egan-Jones Backs DGB's Push for Ethan Allen Shakeup

Updated Category News Views 3

Proxy Fight Brews Over Ethan Allen's Future Here we are, embroiled in another classic showdown in the corporate boardroom, and this time it's over at Ethan Allen—home of those plush couches and dining tables. Egan-Jones proxy services just threw its weight behind all five of DGB Investment's nominees for Ethan Allen’s board. This kind of tug-of-war isn't new, but each...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 0

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Ziihera Extends Survival in Advanced GEA: Big Gains Ahead?

Updated Category News Views 5

A Hard Look at Ziihera's Three-Year Survival Story You know the drill—anytime a new drug pulls weight in the cancer arena, ears perk up. Jazz Pharmaceuticals' recent unveil at the 2026 ESMO Congress caught my attention like a solid run on the NASDAQ. We're looking at Ziihera, tangoing with tislelizumab and chemotherapy, hauling serious results against the nasty fight of...

Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

Updated Category News Views 4

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Continue Reading
Salus Scientific Pioneers Safety at TCT 2026

Updated Category News Views 3

Revolutionizing Occupational Safety in Healthcare Radiation exposure in the medical field: the dull, ominous toll it takes on healthcare professionals, often cloaked in acceptance as a mere occupational hazard. But here's Salus Scientific crashing into the party at TCT 2026 like a seasoned rockstar, demanding we stop accepting the dangers of fluoroscopy-guided procedures...

Continue Reading
Hexagon Composites to Release Q3 2026 Results Soon

Updated Category News Views 3

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 3

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
NorthStar Anesthesia Focuses on ASC Partnerships

Updated Category News Views 2

NorthStar's Growing Partnerships Amid Operational Woes Anesthesia isn’t always the first thing you’d think of in big market-moving terms, but when it comes to keeping ambulatory surgery centers (ASCs) afloat, it might just be the critical stitch. ASCs are getting pinched from all sides—rising costs, staffing nightmares, and those unexpected surgical disruptions that...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: Action Encouraged for Quantum Corporation

Updated Category News Views 159

Investors Taking Action Regarding Quantum Corporation Faruqi & Faruqi, LLP, a respected national securities law firm, is actively investigating claims on behalf of investors who may have suffered losses from their investments in Quantum Corporation. If you are an affected investor, it's crucial to be aware of your rights and potential legal options. Understanding the...

Continue Reading
One Equity Partners Finalizes Sale of Dragonfly Financial Tech

Updated Category News Views 304

One Equity Partners Completes Strategic Sale One Equity Partners (OEP) has finalized an important transition in the financial technology sector with its recent sale of Dragonfly Financial Technologies to FIS. This strategic move reflects OEP's ongoing commitment to fostering technological advancements in the financial services industry. Currently, Dragonfly stands out as...

Continue Reading
Promising Progress of VE303 in Fighting rCDI Proves Hopeful

Updated Category News Views 244

Promising Advances in rCDI Treatment with VE303 Vedanta Biosciences has unveiled exciting findings regarding its leading drug candidate, VE303, aimed at combating recurrent Clostridioides difficile infection (rCDI). The promising outcomes are from the recent Phase 2 study, known as CONSORTIUM, published in the reputable journal Nature Medicine. This trial demonstrated...

Continue Reading
Understanding How Parents Plan and Save for College Costs

Updated Category News Views 178

Understanding Funding Methods for College Education With college tuition costs rising, families are exploring effective strategies to fund their children's education. A recent survey revealed that a remarkable 94% of parents express their commitment to helping their children pay for college. This statistic highlights the determination of families to invest in higher...

Continue Reading
PPG Industries Sees Mixed Earnings: KeyBanc's Outlook

Updated Category News Views 66

PPG Industries' Latest Earnings Report and Analysis Recently, KeyBanc Capital Markets reaffirmed its Overweight rating for PPG Industries (NYSE: PPG), maintaining a price target of $153.00 following the company’s third-quarter earnings release. This period marked a notable moment for PPG, as the earnings per share (EPS) reached $2.13, slightly falling short of market...

Continue Reading